|Last Price||148.13||Max Price||160.53|
|Min Price||66.71||1 Year return||52.55|
The period between December 2015 and December 2016 was a profitable period for the investors in PerkinElmer . The stock gained around 4 percent. Over the period 2011-2016 the stock rose a massive 177,2 percent. PerkinElmer 's revenues between 2011 and 2015 were relatively steady and moved between 2,12 billion dollars and 2,26 billion dollars. During 2011 and 2015 PerkinElmer 's net results were very volatile and fluctuated between 1,17 million dollars and 212,69 million dollars.
PerkinElmer mainly operates in the health care eq. & services sector. The global health care companies gained around 102 percent over the last 10 years. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-2016) there is a plus of 102 percent.
PerkinElmer paid out dividends in the past 5 years. Over the past 5 years the stock delivered an average dividend return of 1,4 percent. In the period 2011 till 2015 PerkinElmer paid it's investors each year a higher dividend per share. Because of the yearly increased dividends PerkinElmer can be called a kind of dividend aristocrat.
At the end of 2015 the American company had a balance sheet of around 4,17 billion dollars. The total debt was around 2,06 billion dollars. This is 49,34 percent of the total balance sheet. Last year the health care company's price/earnings-ratio (PE) was around 22. So the investors valued the stock at 22 times 2015' earnings per share. Based on the classical stock valuation theories the American stock can be seen as a value stock.
The health care company's market capitalization (the number of shares outstanding times the market value) equaled around 5,86 billion dollars. At the end of 2015 the American company had around 112,03 million stocks listed.